Pacira | PCRX - PE Price to Earnings

Stock Price
22.02
Daily Change
0.08 0.36%
Monthly
-5.00%
Yearly
-9.31%
Q1 Forecast
22.56

Pacira reported 52.68 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Astellas Pharma 7.31 2.04 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Heron Therapeutics 6.46 3.23 Dec/2006
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 23.62 0.86 Dec/2025
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Novo Nordisk 12.78 0.01 Dec/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Teva Pharmaceutical Industries 10.11 1.04 Dec/2025
Xoma 52.12 3.09 Sep/2022
Zoetis 20.42 2.84 Dec/2025